Effective Management Of Lu-177-Dota0-Tyr3-Octreotate Extravasation

Radiopharmaceutical extravasation is a known nuclear medicine adverse effect, mostly with no complication in case of diagnostic radiopharmaceutical. However, a therapeutic radiopharmaceutical extravasation may have clinical consequences and must be treated quickly and effectively. We report here a case of Lu-177-DOTA0-Tyr3-octreotate extravasation.